Neuroscience Ireland (NI) was established in 2005 as Ireland’s National Neuroscience Society, and is a registered charity in the Republic of Ireland. NI has a membership in the region of 200 scientists and clinicians, and represents Ireland on the Governing Council of the Federation of European Neuroscience Societies. In this exclusive interview, we speak with Professor Áine Kelly, President of NI, to hear about their vital work driving forward excellence in neuroscience in Ireland and internationally.

To begin, please tell us how Neuroscience Ireland (NI) was established.

Historically, neuroscientists based in Ireland had formed various groups and networks, and organised neuroscience-focussed scientific meetings, but by the early 2000s, it was obvious that to make progress, Ireland needed a single cohesive neuroscience society that was formally constituted. It was also recognised that this society should be affiliated with the Federation of European Neuroscience Societies (FENS). Hence representatives from all major universities in Ireland came together to form the first Council of Neuroscience Ireland (NI), which is celebrating its 15th year as a registered charity and as a FENS member society. Even though we are a young society, we are building on a long history of Irish contributions to brain science that are perhaps not as well-recognised or celebrated as they should be. Neuroscience Ireland aims to remedy that through an ongoing project run by our former President Dr Richard Roche of NUI Maynooth, the Virtual Museum of Irish Brain Science.

What is the overarching vision at NI? As President, what are your aims for the future?

Our stated mission is to advance research and education in the neurosciences in Ireland, and to represent Irish neuroscience researchers both nationally and internationally. That’s quite a wide remit but because of our active membership, we are making continuous progress. Despite chronic underinvestment in neuroscience research, Irish researchers are consistently publishing world-class work in top-tier journals. That’s a message that we really want to get out there – not just to showcase what we are already doing, but to signal what we could achieve given the appropriate financial supports.

As President, my main aims for the future are focussed on building networks and relationships nationally and internationally. At home, Neuroscience Ireland is a key element of the neuroscience network in Ireland, through membership of the Irish Brain Council and association with the Neurological Alliance of Ireland and other charities and patient advocacy groups. We also organise a variety of public engagement activities to highlight the important contribution neuroscientists can make to the health and wellbeing of the Irish people.

Neuroscience Ireland is an all-island society that represents members north and south of the border. Recently, we have been delighted to welcome new members from the University of Ulster and Queens University Belfast to our Council and we are hoping to increase and strengthen those north-south links and expand our membership across the island. Our next ‘Young Neuroscience Symposium’, a biennial scientific meeting focussed on early career researchers, is being organised by our colleagues based in Northern Ireland and will be held in November. Due to COVID-19, it will be a virtual event but the society hopes to host one of our in-person scientific meetings in Northern Ireland at some time in the future.

Ireland is a small country but we make disproportionately large contributions to science, as in many areas, due to our ability to build strong and lasting working relationships. Just as Ireland sees its future within Europe, Neuroscience Ireland sees membership of FENS as key to its future success. Two Irish members, myself and former President Dr Eilís Dowd of NUI Galway, currently sit on the Governing Council, and we have three members on the FENS’ standing committees. Having a voice at the European level is especially important as we continue to advocate for that important increased investment. We also have a particularly strong relationship with another FENS member society – the British Neuroscience Association (BNA) – with whom we have co-hosted scientific meetings. We want to see this relationship continue to flourish, notwithstanding the complex political and economic climate resulting from Brexit.

Overall, I want to grow the society and to engender within the membership a sense of belonging to a society that represents Ireland’s neuroscience community in all its geographic and disciplinary diversity.

‘Our stated mission is to advance research and education in the neurosciences in Ireland, and to represent Irish neuroscience researchers both nationally and internationally.’

How do you promote education and training for neuroscientists?

I sit on the FENS Committee for Higher Education and Training, so this area is a particular interest of mine. We are fortunate to have a talented pool of young researchers in universities throughout the country. We support these researchers in practical ways, by organising annual scientific meetings where they can share results and connect with each other and with international invitees and speakers. Every second year, this meeting takes the form of the Young Neuroscience Symposium mentioned above, which has a special emphasis on mentorship, networking and career development. We also provide travel bursaries to students and early career members to enable them to attend international conferences. All Neuroscience Ireland members are automatically members of FENS, which opens up huge opportunities for training and career development including the FENS summer schools and winter schools and the CAJAL Advanced Neuroscience Training Programme.

Do you provide funding opportunities for researchers?

We are a small society with limited resources, so we don’t have a budget to fund research directly. Instead, we channel our resources into providing funding for conference attendance to help researchers build their networks. We also provide small grants to help researchers host international conferences in Ireland.

In your opinion, what can neuroscience specifically bring to translational research and medicine?

In Ireland alone, over 800,000 people live with neurological conditions such as stroke, epilepsy, Parkinson’s disease, Alzheimer’s disease and multiple sclerosis and the associated costs are estimated to be €3 billion per annum. This is both a personal and a societal crisis, placing an enormous burden on healthcare systems. I think that improved diagnostics and treatments will only come from the type of interdisciplinary collaboration that characterises neuroscience. In Neuroscience Ireland we recognise this by ensuring disciplinary diversity within our Council membership by including clinicians and clinician-scientists, along with researchers working in basic and preclinical neuroscience research.

At the research level, relatively recent technologies like optogenetics have given neuroscientists better tools to explore and attempt to understand fundamental neurophysiological processes and disease processes. While these have the potential for therapeutic use, their invasive nature is an obvious drawback that must be overcome. But importantly, as has always been the case in scientific research, hypotheses, concepts and theoretical frameworks of understanding need to evolve alongside technologies if newly-discovered mechanistic information is to be applied for human benefit.

‘There will continue to be huge opportunities to apply knowledge from neuroscience research to different aspects of economic or societal activity…this is where scientific communication and public understanding of science are key.’

In recent years, neuroscience has given rise to a range of applied disciplines including neuroeconomics, neuroethics, and neurolaw. What opportunities and challenges do you see on the horizon as a result of this expansion of the application of neuroscience?

Many neuroscientists are very wary of the recent trend for sticking the ‘neuro’ prefix in front of an existing disciplinary name and heralding the arrival of a new discipline. It is not always helpful and can, in fact, be harmful if neuroscience findings are applied in an uninformed, misinformed or premature manner. One clear example here is of the increasing introduction, especially in the USA, of imaging data into the courtroom, where jurors or judges may not have the knowledge to understand the validity of the evidence or the scientific concepts being presented. That being said, there will continue to be huge opportunities to apply knowledge from neuroscience research to different aspects of economic or societal activity. To me, this is where scientific communication and public understanding of science are key. Researchers have a responsibility to communicate their findings to the public directly and in a considered and clear manner. We all have a part to play in ensuring the continuing credibility of scientists and public trust in the scientific enterprise.

E: neuroscience.ireland@gmail.com

W: https://neuroscienceireland.com/

Twitter: @NeuroscienceIRL

Reference
https://doi.org/10.33548/SCIENTIA561

Want to republish our articles?

 

We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more

Creative Commons Licence
(CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Subscribe now!


More articles you may like

Dr Michael Wangler – Using Genetics to Diagnose Rare Metabolic Diseases

Dr Michael Wangler – Using Genetics to Diagnose Rare Metabolic Diseases

Identifying the cause of an illness in a sick baby or child is not always easy, particularly if the disease is rare. Throughout his career, Dr Michael Wangler, at the Baylor College of Medicine and Jan and Dan Duncan Neurological Research Institute, has investigated rare childhood diseases. Combining his expertise in paediatrics and genetics, Dr Wangler utilises genomics, metabolomics and the humble fruit fly to identify the genes responsible for rare and undiagnosed diseases to improve both diagnosis and treatment.

Dr Stephen Kry – Improving the Quality and Accuracy of Radiotherapy Through Research

Dr Stephen Kry – Improving the Quality and Accuracy of Radiotherapy Through Research

Radiation therapy is an effective and widely used method of treating cancer, and as with any treatment, it is essential to get the right dose. However, Dr Stephen Kry from The University of Texas MD Anderson Cancer Center has found widespread errors in the systems that calculate the doses patients receive. Through his research, he has helped to identify where these errors occur, how common they are, and provide possible solutions. He hopes that his work will go on to improve the quality and efficacy of radiotherapy for many cancer patients.

Dr Peter Bretscher – A Substantiated Framework for the Prevention and Treatment of Immune System-Related Diseases

Dr Peter Bretscher – A Substantiated Framework for the Prevention and Treatment of Immune System-Related Diseases

Immunity is generated normally against invaders, such as viruses and cancer cells, but not against parts of the body to which the immune system belongs. In 1970, Dr Peter Bretscher and Dr Melvin Cohn proposed a theory to account for how this is achieved. Importantly, immune responses against invaders can take one of two main forms, and Dr Bretscher (currently at the University of Saskatchewan) also proposed an explanation for how the choice of immunity is made. These two proposals are supported by diverse findings. Here, we outline and justify these proposals and explain how they lead to strategies to prevent and treat diverse diseases.

Dr Lakshmi Mahadevan – Mental Health First Aid: Bridging the Gap between Rural Communities and Access to Care

Dr Lakshmi Mahadevan – Mental Health First Aid: Bridging the Gap between Rural Communities and Access to Care

In the USA, poor mental health and opioid addiction are prominent and widespread. With a lack of understanding and resources in many rural areas in Texas, many people facing mental health and addiction challenges do not know where to turn. Dr Lakshmi Mahadevan at Texas A&M AgriLife Extension Service is helping to train up rural communities in Mental Health First Aid (MFHA) so that they can provide better care for those in need.